Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer

WEDNESDAY, Oct. 30, 2024 -- For patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy, according to a study published online Oct. 23 in The BMJ.
Min He, from Fudan University Shanghai...